Ouyang T - Search Results

1

Identification and characterization of a nuclear interacting partner of anaplastic lymphoma kinase (NIPA).

Ouyang T, Bai RY, Bassermann F, von Klitzing C, Klumpen S, Miething C, Morris SW, Peschel C, Duyster J. Ouyang T, et al. J Biol Chem. 2003 Aug 8;278(32):30028-36. doi: 10.1074/jbc.M300883200. Epub 2003 May 14. J Biol Chem. 2003. PMID: 12748172 Free article.

2

SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling.

Bai RY, Koester C, Ouyang T, Hahn SA, Hammerschmidt M, Peschel C, Duyster J. Bai RY, et al. Among authors: ouyang t. Nat Cell Biol. 2002 Mar;4(3):181-90. doi: 10.1038/ncb753. Nat Cell Biol. 2002. PMID: 11836524

3

Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.

Bai RY, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J. Bai RY, et al. Among authors: ouyang t. Blood. 2000 Dec 15;96(13):4319-27. Blood. 2000. PMID: 11110708 Free article.

4

A novel peptide isolated from a phage display peptide library with trastuzumab can mimic antigen epitope of HER-2.

Jiang B, Liu W, Qu H, Meng L, Song S, Ouyang T, Shou C. Jiang B, et al. Among authors: ouyang t. J Biol Chem. 2005 Feb 11;280(6):4656-62. doi: 10.1074/jbc.M411047200. Epub 2004 Nov 9. J Biol Chem. 2005. PMID: 15536075 Free article.

5

Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.

Han X, Diao L, Xu Y, Xue W, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Han X, et al. Among authors: ouyang t. Ann Oncol. 2014 Jun;25(6):1158-64. doi: 10.1093/annonc/mdu111. Epub 2014 Mar 7. Ann Oncol. 2014. PMID: 24608202 Free article.

6

[Impact of the response of primary tumor to preoperative chemotherapy and anti-HER2 therapy on survival of HER2-positive breast cancer patients].

Wang ZJ, He YJ, Li JF, Xie YT, Wang TF, Fan ZQ, Fan T, Ouyang T. Wang ZJ, et al. Among authors: ouyang t. Zhonghua Yi Xue Za Zhi. 2016 Aug 23;96(32):2578-82. doi: 10.3760/cma.j.issn.0376-2491.2016.32.013. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27596555 Chinese.

7

Association of p73 G4C14-to-A4T14 (GC/AT) polymorphism with breast cancer survival.

Li H, Yao L, Ouyang T, Li J, Wang T, Fan Z, Fan T, Dong B, Lin B, Li J, Xie Y. Li H, et al. Among authors: ouyang t. Carcinogenesis. 2007 Feb;28(2):372-7. doi: 10.1093/carcin/bgl153. Epub 2006 Aug 31. Carcinogenesis. 2007. PMID: 16950799

8

Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Wang Z, Xie Y. Shi L, et al. Among authors: ouyang t. J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487384 Free PMC article.

9

HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.

Wang T, Xu Y, Sheng S, Yuan H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Wang T, et al. Among authors: ouyang t. Cancer Sci. 2017 Apr;108(4):671-677. doi: 10.1111/cas.13182. Epub 2017 Apr 21. Cancer Sci. 2017. PMID: 28164408 Free PMC article.

10

Somatic mutations in the BRCA1 gene in Chinese women with sporadic breast cancer.

Zhang M, Xu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. Zhang M, et al. Among authors: ouyang t. Breast Cancer Res Treat. 2012 Feb;132(1):335-40. doi: 10.1007/s10549-011-1887-2. Epub 2011 Nov 25. Breast Cancer Res Treat. 2012. PMID: 22116506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters